TRANSITION THERAPEUTICS INC's ticker is TTHI and the CUSIP is 893716209. A total of 30 filers reported holding TRANSITION THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $414,000 | +24.0% | 281,400 | +7.8% | 0.00% | 0.0% |
| Q1 2016 | $334,000 | -26.4% | 261,000 | +10.4% | 0.00% | 0.0% |
| Q4 2015 | $454,000 | +24.0% | 236,400 | +15.8% | 0.00% | 0.0% |
| Q3 2015 | $366,000 | -2.9% | 204,200 | +13.9% | 0.00% | 0.0% |
| Q2 2015 | $377,000 | -71.0% | 179,300 | -6.0% | 0.00% | -66.7% |
| Q1 2015 | $1,302,000 | +8.6% | 190,700 | +8.7% | 0.00% | 0.0% |
| Q4 2014 | $1,199,000 | +16.1% | 175,400 | +17.2% | 0.00% | 0.0% |
| Q3 2014 | $1,033,000 | +17.1% | 149,700 | +14.0% | 0.00% | +50.0% |
| Q2 2014 | $882,000 | -15.6% | 131,300 | +0.2% | 0.00% | -33.3% |
| Q1 2014 | $1,045,000 | +53.2% | 131,100 | +9.4% | 0.00% | +50.0% |
| Q4 2013 | $682,000 | +130.4% | 119,800 | +65.5% | 0.00% | +100.0% |
| Q3 2013 | $296,000 | +199.0% | 72,400 | +135.8% | 0.00% | – |
| Q2 2013 | $99,000 | – | 30,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 4,863,914 | $10,214,000 | 1.24% |
| Birchview Capital, LP | 145,746 | $306,000 | 0.16% |
| DAFNA Capital Management LLC | 59,222 | $124,000 | 0.10% |
| HOLLENCREST CAPITAL MANAGEMENT | 162,196 | $341,000 | 0.05% |
| VESTOR CAPITAL, LLC | 42,600 | $89,000 | 0.03% |
| Plante Moran Financial Advisors, LLC | 17,034 | $36,000 | 0.03% |
| SABBY MANAGEMENT, LLC | 302,837 | $636,000 | 0.02% |
| SPHERA FUNDS MANAGEMENT LTD. | 70,273 | $148,000 | 0.01% |
| FineMark National Bank & Trust | 22,807 | $48,000 | 0.01% |
| Alyeska Investment Group, L.P. | 394,858 | $830,000 | 0.01% |